Epica International
Epica International provides robotic CT platforms for healthcare and industrial applications. Its medical offering includes Ortis, a 7-axis carving robotic arm used to produce custom-made prosthetic and orthotic models, and CT imaging systems for diagnosing and treating medical and veterinary patient conditions. The company combines robotics with advanced imaging to automate the production of patient-specific…
Funding snapshot
About
Epica International provides robotic CT platforms for healthcare and industrial applications. Its medical offering includes Ortis, a 7-axis carving robotic arm used to produce custom-made prosthetic and orthotic models, and CT imaging systems for diagnosing and treating medical and veterinary patient conditions. The company combines robotics with advanced imaging to automate the production of patient-specific medical devices and provide diagnostic imaging solutions. Founded in 2014 and headquartered in San Clemente, United States, Epica International has raised approximately $25.7M in Series B funding from investors including Avenue Capital Group, Partners For Growth, SWK Holdings, and Facilitated Growth. The company employs 27 people and serves both medical and veterinary markets, addressing the need for precision in prosthetic manufacturing and high-quality CT imaging for specialized diagnostic applications.
Business model
Consumer Robotics > Healthcare > Robotic Assistance > Prosthetics,
Professional Service Robots > Healthcare > Surgery,
Assistive Tech > Assistive Hardware > Mobility > Robotic Arms > Eating Devices,
Orthopedics > Medical Devices > Therapies > Rehabilitation > Prosthetics,
Surgical Instruments > Robotic Surgery
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.